---
title: "MCI ë…¼ë¬¸ ë™í–¥ ë¦¬í¬íŠ¸ (2025-08-01)"
date: 2025-08-01
categories: [neuroscience, imaging, ai_ml, clinical_study, cognitive_assessment, biomarker]
tags: [MCI, Research, Trends, Papers]
author: "CLAIR"
showToc: true
TocOpen: false
draft: false
hidemeta: false
comments: true
description: "MCI ê´€ë ¨ ìµœì‹  ë…¼ë¬¸ ìš”ì•½ ë° ì—°êµ¬ ë™í–¥ ë¶„ì„"
---

# ğŸ§  MCI ì—°êµ¬ ë™í–¥ ë¦¬í¬íŠ¸

> **ìƒì„±ì¼**: 2025ë…„ 08ì›” 01ì¼  
> **ìˆ˜ì§‘ ë…¼ë¬¸ ìˆ˜**: 34ê°œ

---

## ğŸ“Š ì—°êµ¬ ë™í–¥ ë¶„ì„


## ğŸ“ˆ ì—°êµ¬ ë™í–¥ ìš”ì•½

ìµœê·¼ ìˆ˜ì§‘ëœ 20í¸ì˜ MCI ê´€ë ¨ ë…¼ë¬¸ì„ ë¶„ì„í•œ ê²°ê³¼:

### ì£¼ìš” ì—°êµ¬ ì˜ì—­
- **clinical_study**: 11í¸ (55.0%)
- **cognitive_assessment**: 11í¸ (55.0%)
- **biomarker**: 9í¸ (45.0%)
- **neuroscience**: 7í¸ (35.0%)
- **imaging**: 5í¸ (25.0%)
- **ai_ml**: 2í¸ (10.0%)

### ì—°êµ¬ ë™í–¥ íŠ¹ì§•
- MCI ì§„ë‹¨ ë° ì¹˜ë£Œë²• ê°œë°œì— ëŒ€í•œ ì—°êµ¬ê°€ í™œë°œíˆ ì§„í–‰ë˜ê³  ìˆìŠµë‹ˆë‹¤
- ì‹ ê²½ì˜ìƒí•™ì  ë°”ì´ì˜¤ë§ˆì»¤ ì—°êµ¬ê°€ ì§€ì†ì ìœ¼ë¡œ ì¦ê°€í•˜ê³  ìˆìŠµë‹ˆë‹¤
- ì¸ê³µì§€ëŠ¥ì„ í™œìš©í•œ ì¡°ê¸° ì§„ë‹¨ ì—°êµ¬ê°€ ì£¼ëª©ë°›ê³  ìˆìŠµë‹ˆë‹¤


---

## ğŸ“š ìµœì‹  ë…¼ë¬¸ ìš”ì•½

### ğŸ§¬ ì‹ ê²½ê³¼í•™

#### 1. Lower hippocampal volumes at baseline are associated with higher volume loss in healthy elderly.

**ğŸ“– ì €ë„**: Frontiers in aging neuroscience Vol.17 (2025)

**ğŸ”— PubMed**: [40741045](https://pubmed.ncbi.nlm.nih.gov/40741045/)

**ğŸ“ ìš”ì•½**: Hippocampal volume loss occurs physiologically with age, but an accelerated rate of volume loss is linked to neurodegenerative diseases. While evidence suggests that cross-sectional study designs tend to underestimate hippocampal atrophy rates compared to longitudinal approaches, few studies have directly examined the relationship between these two methods in the context of brain aging.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: neuroscience, imaging

---

#### 2. Quantitative assessment of brain glymphatic imaging features using deep learning-based EPVS segmentation and DTI-ALPS analysis in Alzheimer's disease.

**ğŸ“– ì €ë„**: Frontiers in aging neuroscience Vol.17 (2025)

**ğŸ”— PubMed**: [40741044](https://pubmed.ncbi.nlm.nih.gov/40741044/)

**ğŸ“ ìš”ì•½**: This study aimed to quantitatively evaluate brain glymphatic imaging features in patients with Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI), and normal controls (NC) by applying a deep learning-based method for the automated segmentation of enlarged perivascular space (EPVS) and diffusion tensor imaging analysis along perivascular spaces (DTI-ALPS) indices. A total of 89 patients with AD, 24 aMCI, and 32 NCs were included.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: ai_ml, clinical_study, cognitive_assessment, neuroscience, imaging

---

#### 3. Learning Patient-Specific Spatial Biomarker Dynamics via Operator Learning for Alzheimer's Disease Progression.

**ğŸ“– ì €ë„**: ArXiv (2025)

**ğŸ”— PubMed**: [40740514](https://pubmed.ncbi.nlm.nih.gov/40740514/)

**ğŸ“ ìš”ì•½**: Alzheimer's disease (AD) is a complex, multifactorial neurodegenerative disorder with substantial heterogeneity in progression and treatment response. Despite recent therapeutic advances, predictive models capable of accurately forecasting individualized disease trajectories remain limited.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, ai_ml, clinical_study, neuroscience, imaging

---

#### 4. CSF and blood neuronal injury biomarkers in spinal bulbar muscular atrophy and amyotrophic lateral sclerosis 4.

**ğŸ“– ì €ë„**: Brain communications Vol.7 Issue.4 (2025)

**ğŸ”— PubMed**: [40740433](https://pubmed.ncbi.nlm.nih.gov/40740433/)

**ğŸ“ ìš”ì•½**: Spinal and bulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis 4 (ALS4) are two forms of motor neuron disease characterized by clinically slow disease progression. Based on the current limited human studies, the contribution of central nervous neurodegeneration to these diseases and the rate of clinical progression is unclear.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, clinical_study, neuroscience

---

#### 5. Adverse childhood experiences influence markers of neurodegeneration risk in older adults.

**ğŸ“– ì €ë„**: Alzheimer's & dementia : the journal of the Alzheimer's Association Vol.21 Issue.8 (2025)

**ğŸ”— PubMed**: [40739680](https://pubmed.ncbi.nlm.nih.gov/40739680/)

**ğŸ“ ìš”ì•½**: Adverse childhood experiences (ACEs) disrupt brain development and increase vulnerability to Alzheimer's disease and related dementias (ADRD). We explored how ACEs impact neuroimaging, plasma biomarkers, and cognition in older adults.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, cognitive_assessment, neuroscience, imaging

---

### ğŸ“¸ ì´ë¯¸ì§•

#### 1. Lower hippocampal volumes at baseline are associated with higher volume loss in healthy elderly.

**ğŸ“– ì €ë„**: Frontiers in aging neuroscience Vol.17 (2025)

**ğŸ”— PubMed**: [40741045](https://pubmed.ncbi.nlm.nih.gov/40741045/)

**ğŸ“ ìš”ì•½**: Hippocampal volume loss occurs physiologically with age, but an accelerated rate of volume loss is linked to neurodegenerative diseases. While evidence suggests that cross-sectional study designs tend to underestimate hippocampal atrophy rates compared to longitudinal approaches, few studies have directly examined the relationship between these two methods in the context of brain aging.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: neuroscience, imaging

---

#### 2. Quantitative assessment of brain glymphatic imaging features using deep learning-based EPVS segmentation and DTI-ALPS analysis in Alzheimer's disease.

**ğŸ“– ì €ë„**: Frontiers in aging neuroscience Vol.17 (2025)

**ğŸ”— PubMed**: [40741044](https://pubmed.ncbi.nlm.nih.gov/40741044/)

**ğŸ“ ìš”ì•½**: This study aimed to quantitatively evaluate brain glymphatic imaging features in patients with Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI), and normal controls (NC) by applying a deep learning-based method for the automated segmentation of enlarged perivascular space (EPVS) and diffusion tensor imaging analysis along perivascular spaces (DTI-ALPS) indices. A total of 89 patients with AD, 24 aMCI, and 32 NCs were included.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: ai_ml, clinical_study, cognitive_assessment, neuroscience, imaging

---

#### 3. Learning Patient-Specific Spatial Biomarker Dynamics via Operator Learning for Alzheimer's Disease Progression.

**ğŸ“– ì €ë„**: ArXiv (2025)

**ğŸ”— PubMed**: [40740514](https://pubmed.ncbi.nlm.nih.gov/40740514/)

**ğŸ“ ìš”ì•½**: Alzheimer's disease (AD) is a complex, multifactorial neurodegenerative disorder with substantial heterogeneity in progression and treatment response. Despite recent therapeutic advances, predictive models capable of accurately forecasting individualized disease trajectories remain limited.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, ai_ml, clinical_study, neuroscience, imaging

---

#### 4. FBXO7 Pathogenic Variants in Early-Onset Parkinsonism: Insights from a Neuroimaging Perspective and Review of the Literature.

**ğŸ“– ì €ë„**: Movement disorders clinical practice (2025)

**ğŸ”— PubMed**: [40740144](https://pubmed.ncbi.nlm.nih.gov/40740144/)

**ğŸ“ ìš”ì•½**: Early onset parkinsonism caused by F-box only protein7 (FBXO7) pathogenic variants is a rare autosomal recessive disorder presenting with a combination of parkinsonism, pyramidal signs, dystonia, cognitive impairment, and psychiatric features. Although previous case reports have mentioned neuroimaging findings, there is no comprehensive study characterizing the radiological spectrum of FBXO7 pathogenic variants.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, clinical_study, cognitive_assessment, imaging

---

#### 5. Adverse childhood experiences influence markers of neurodegeneration risk in older adults.

**ğŸ“– ì €ë„**: Alzheimer's & dementia : the journal of the Alzheimer's Association Vol.21 Issue.8 (2025)

**ğŸ”— PubMed**: [40739680](https://pubmed.ncbi.nlm.nih.gov/40739680/)

**ğŸ“ ìš”ì•½**: Adverse childhood experiences (ACEs) disrupt brain development and increase vulnerability to Alzheimer's disease and related dementias (ADRD). We explored how ACEs impact neuroimaging, plasma biomarkers, and cognition in older adults.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, cognitive_assessment, neuroscience, imaging

---

### ğŸ¤– AI/ë¨¸ì‹ ëŸ¬ë‹

#### 1. Quantitative assessment of brain glymphatic imaging features using deep learning-based EPVS segmentation and DTI-ALPS analysis in Alzheimer's disease.

**ğŸ“– ì €ë„**: Frontiers in aging neuroscience Vol.17 (2025)

**ğŸ”— PubMed**: [40741044](https://pubmed.ncbi.nlm.nih.gov/40741044/)

**ğŸ“ ìš”ì•½**: This study aimed to quantitatively evaluate brain glymphatic imaging features in patients with Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI), and normal controls (NC) by applying a deep learning-based method for the automated segmentation of enlarged perivascular space (EPVS) and diffusion tensor imaging analysis along perivascular spaces (DTI-ALPS) indices. A total of 89 patients with AD, 24 aMCI, and 32 NCs were included.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: ai_ml, clinical_study, cognitive_assessment, neuroscience, imaging

---

#### 2. Learning Patient-Specific Spatial Biomarker Dynamics via Operator Learning for Alzheimer's Disease Progression.

**ğŸ“– ì €ë„**: ArXiv (2025)

**ğŸ”— PubMed**: [40740514](https://pubmed.ncbi.nlm.nih.gov/40740514/)

**ğŸ“ ìš”ì•½**: Alzheimer's disease (AD) is a complex, multifactorial neurodegenerative disorder with substantial heterogeneity in progression and treatment response. Despite recent therapeutic advances, predictive models capable of accurately forecasting individualized disease trajectories remain limited.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, ai_ml, clinical_study, neuroscience, imaging

---

### ğŸ¥ ì„ìƒì—°êµ¬

#### 1. Quantitative assessment of brain glymphatic imaging features using deep learning-based EPVS segmentation and DTI-ALPS analysis in Alzheimer's disease.

**ğŸ“– ì €ë„**: Frontiers in aging neuroscience Vol.17 (2025)

**ğŸ”— PubMed**: [40741044](https://pubmed.ncbi.nlm.nih.gov/40741044/)

**ğŸ“ ìš”ì•½**: This study aimed to quantitatively evaluate brain glymphatic imaging features in patients with Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI), and normal controls (NC) by applying a deep learning-based method for the automated segmentation of enlarged perivascular space (EPVS) and diffusion tensor imaging analysis along perivascular spaces (DTI-ALPS) indices. A total of 89 patients with AD, 24 aMCI, and 32 NCs were included.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: ai_ml, clinical_study, cognitive_assessment, neuroscience, imaging

---

#### 2. Memory Function in Euthymic Patients with Bipolar I Disorder: A Cross-Sectional Study of Clinical and Demographic Correlates.

**ğŸ“– ì €ë„**: Medical journal of the Islamic Republic of Iran Vol.39 (2025)

**ğŸ”— PubMed**: [40740572](https://pubmed.ncbi.nlm.nih.gov/40740572/)

**ğŸ“ ìš”ì•½**: Memory is one of the most affected cognitive domains in patients with Bipolar I Disorder, even during periods of euthymia. This study aimed to investigate the relationship between certain clinical and demographic variables and the domains of memory function in euthymic bipolar I patients.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: clinical_study, cognitive_assessment

---

#### 3. Learning Patient-Specific Spatial Biomarker Dynamics via Operator Learning for Alzheimer's Disease Progression.

**ğŸ“– ì €ë„**: ArXiv (2025)

**ğŸ”— PubMed**: [40740514](https://pubmed.ncbi.nlm.nih.gov/40740514/)

**ğŸ“ ìš”ì•½**: Alzheimer's disease (AD) is a complex, multifactorial neurodegenerative disorder with substantial heterogeneity in progression and treatment response. Despite recent therapeutic advances, predictive models capable of accurately forecasting individualized disease trajectories remain limited.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, ai_ml, clinical_study, neuroscience, imaging

---

#### 4. Effects of repetitive transcranial magnetic stimulation on electroencephalogram and memory function in patients with mild cognitive impairment.

**ğŸ“– ì €ë„**: World journal of psychiatry Vol.15 Issue.7 (2025)

**ğŸ”— PubMed**: [40740460](https://pubmed.ncbi.nlm.nih.gov/40740460/)

**ğŸ“ ìš”ì•½**: Mild cognitive impairment (MCI) is a high-risk precursor to Alzheimer's disease characterized by declining memory or other progressive cognitive functions without compromising daily living abilities. To investigate the efficacy of repetitive transcranial magnetic stimulation (rTMS) in patients with MCI.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: clinical_study, cognitive_assessment

---

#### 5. CSF and blood neuronal injury biomarkers in spinal bulbar muscular atrophy and amyotrophic lateral sclerosis 4.

**ğŸ“– ì €ë„**: Brain communications Vol.7 Issue.4 (2025)

**ğŸ”— PubMed**: [40740433](https://pubmed.ncbi.nlm.nih.gov/40740433/)

**ğŸ“ ìš”ì•½**: Spinal and bulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis 4 (ALS4) are two forms of motor neuron disease characterized by clinically slow disease progression. Based on the current limited human studies, the contribution of central nervous neurodegeneration to these diseases and the rate of clinical progression is unclear.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, clinical_study, neuroscience

---

### ğŸ§ª ì¸ì§€í‰ê°€

#### 1. Quantitative assessment of brain glymphatic imaging features using deep learning-based EPVS segmentation and DTI-ALPS analysis in Alzheimer's disease.

**ğŸ“– ì €ë„**: Frontiers in aging neuroscience Vol.17 (2025)

**ğŸ”— PubMed**: [40741044](https://pubmed.ncbi.nlm.nih.gov/40741044/)

**ğŸ“ ìš”ì•½**: This study aimed to quantitatively evaluate brain glymphatic imaging features in patients with Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI), and normal controls (NC) by applying a deep learning-based method for the automated segmentation of enlarged perivascular space (EPVS) and diffusion tensor imaging analysis along perivascular spaces (DTI-ALPS) indices. A total of 89 patients with AD, 24 aMCI, and 32 NCs were included.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: ai_ml, clinical_study, cognitive_assessment, neuroscience, imaging

---

#### 2. The Diagnostic Performance of Screening Instruments for Mild Cognitive Impairment and Dementia in Chronic Kidney Disease and Kidney Failure: A Systematic Review and Meta-analysis.

**ğŸ“– ì €ë„**: Kidney medicine Vol.7 Issue.8 (2025)

**ğŸ”— PubMed**: [40740722](https://pubmed.ncbi.nlm.nih.gov/40740722/)

**ğŸ“ ìš”ì•½**: Mild cognitive impairment (MCI) and dementia disproportionately affect people with chronic kidney disease (CKD) and kidney failure. Screening instruments can accurately identify cognitive impairment in the general population, but their performance in the setting of kidney disease is unclear.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: cognitive_assessment

---

#### 3. Memory Function in Euthymic Patients with Bipolar I Disorder: A Cross-Sectional Study of Clinical and Demographic Correlates.

**ğŸ“– ì €ë„**: Medical journal of the Islamic Republic of Iran Vol.39 (2025)

**ğŸ”— PubMed**: [40740572](https://pubmed.ncbi.nlm.nih.gov/40740572/)

**ğŸ“ ìš”ì•½**: Memory is one of the most affected cognitive domains in patients with Bipolar I Disorder, even during periods of euthymia. This study aimed to investigate the relationship between certain clinical and demographic variables and the domains of memory function in euthymic bipolar I patients.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: clinical_study, cognitive_assessment

---

#### 4. Effects of repetitive transcranial magnetic stimulation on electroencephalogram and memory function in patients with mild cognitive impairment.

**ğŸ“– ì €ë„**: World journal of psychiatry Vol.15 Issue.7 (2025)

**ğŸ”— PubMed**: [40740460](https://pubmed.ncbi.nlm.nih.gov/40740460/)

**ğŸ“ ìš”ì•½**: Mild cognitive impairment (MCI) is a high-risk precursor to Alzheimer's disease characterized by declining memory or other progressive cognitive functions without compromising daily living abilities. To investigate the efficacy of repetitive transcranial magnetic stimulation (rTMS) in patients with MCI.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: clinical_study, cognitive_assessment

---

#### 5. Association between weight-adjusted waist circumference index and risk of cognitive decline in Chinese hypertensive patients: a case-control study.

**ğŸ“– ì €ë„**: Frontiers in public health Vol.13 (2025)

**ğŸ”— PubMed**: [40740373](https://pubmed.ncbi.nlm.nih.gov/40740373/)

**ğŸ“ ìš”ì•½**: As a new obesity-related index, the weight-adjusted waist circumference index (WWI) seems to be a good predictor of cognitive decline in hypertensive patients. This study aimed to verify the relationship between WWI and cognitive decline in Chinese hypertensive patients.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: clinical_study, cognitive_assessment

---

### ğŸ“‹ ê¸°íƒ€

#### 1. Reduction of the Ca

**ğŸ“– ì €ë„**: Frontiers in cellular neuroscience Vol.19 (2025)

**ğŸ”— PubMed**: [40740969](https://pubmed.ncbi.nlm.nih.gov/40740969/)

**ğŸ“ ìš”ì•½**: Excitotoxic damage is due to an excessive Ca

---

#### 2. Research progress on immunometabolism and gut microbiota in cryptococcal meningitis: mechanisms and therapeutic implications.

**ğŸ“– ì €ë„**: Frontiers in neuroscience Vol.19 (2025)

**ğŸ”— PubMed**: [40740256](https://pubmed.ncbi.nlm.nih.gov/40740256/)

**ğŸ“ ìš”ì•½**: Cryptococcal meningitis (CM) is a fatal central nervous system infection caused by

---

### ğŸ”¬ ë°”ì´ì˜¤ë§ˆì»¤

#### 1. Learning Patient-Specific Spatial Biomarker Dynamics via Operator Learning for Alzheimer's Disease Progression.

**ğŸ“– ì €ë„**: ArXiv (2025)

**ğŸ”— PubMed**: [40740514](https://pubmed.ncbi.nlm.nih.gov/40740514/)

**ğŸ“ ìš”ì•½**: Alzheimer's disease (AD) is a complex, multifactorial neurodegenerative disorder with substantial heterogeneity in progression and treatment response. Despite recent therapeutic advances, predictive models capable of accurately forecasting individualized disease trajectories remain limited.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, ai_ml, clinical_study, neuroscience, imaging

---

#### 2. CSF and blood neuronal injury biomarkers in spinal bulbar muscular atrophy and amyotrophic lateral sclerosis 4.

**ğŸ“– ì €ë„**: Brain communications Vol.7 Issue.4 (2025)

**ğŸ”— PubMed**: [40740433](https://pubmed.ncbi.nlm.nih.gov/40740433/)

**ğŸ“ ìš”ì•½**: Spinal and bulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis 4 (ALS4) are two forms of motor neuron disease characterized by clinically slow disease progression. Based on the current limited human studies, the contribution of central nervous neurodegeneration to these diseases and the rate of clinical progression is unclear.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, clinical_study, neuroscience

---

#### 3. Longitudinal effects of sex differences and apolipoprotein E genotype on white matter engagement among elderly.

**ğŸ“– ì €ë„**: Brain communications Vol.7 Issue.4 (2025)

**ğŸ”— PubMed**: [40740432](https://pubmed.ncbi.nlm.nih.gov/40740432/)

**ğŸ“ ìš”ì•½**: The apolipoprotein E (

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker

---

#### 4. FBXO7 Pathogenic Variants in Early-Onset Parkinsonism: Insights from a Neuroimaging Perspective and Review of the Literature.

**ğŸ“– ì €ë„**: Movement disorders clinical practice (2025)

**ğŸ”— PubMed**: [40740144](https://pubmed.ncbi.nlm.nih.gov/40740144/)

**ğŸ“ ìš”ì•½**: Early onset parkinsonism caused by F-box only protein7 (FBXO7) pathogenic variants is a rare autosomal recessive disorder presenting with a combination of parkinsonism, pyramidal signs, dystonia, cognitive impairment, and psychiatric features. Although previous case reports have mentioned neuroimaging findings, there is no comprehensive study characterizing the radiological spectrum of FBXO7 pathogenic variants.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, clinical_study, cognitive_assessment, imaging

---

#### 5. Adverse childhood experiences influence markers of neurodegeneration risk in older adults.

**ğŸ“– ì €ë„**: Alzheimer's & dementia : the journal of the Alzheimer's Association Vol.21 Issue.8 (2025)

**ğŸ”— PubMed**: [40739680](https://pubmed.ncbi.nlm.nih.gov/40739680/)

**ğŸ“ ìš”ì•½**: Adverse childhood experiences (ACEs) disrupt brain development and increase vulnerability to Alzheimer's disease and related dementias (ADRD). We explored how ACEs impact neuroimaging, plasma biomarkers, and cognition in older adults.

**ğŸ·ï¸ ì¹´í…Œê³ ë¦¬**: biomarker, cognitive_assessment, neuroscience, imaging

---


## ğŸ’¡ ì´ìš© ì•ˆë‚´

- **ë…¼ë¬¸ ì›ë¬¸**: PubMed ë§í¬ë¥¼ í†µí•´ ì „ë¬¸ì„ í™•ì¸í•˜ì‹¤ ìˆ˜ ìˆìŠµë‹ˆë‹¤.
- **ì—…ë°ì´íŠ¸**: ë§¤ì¼ ì˜¤ì „ 7ì‹œ(JST)ì— ìƒˆë¡œìš´ ë…¼ë¬¸ì´ ìë™ìœ¼ë¡œ ì¶”ê°€ë©ë‹ˆë‹¤.
- **í”¼ë“œë°±**: ê°œì„  ì‚¬í•­ì´ë‚˜ ì˜¤ë¥˜ ë°œê²¬ ì‹œ GitHub ì´ìŠˆë¡œ ì•Œë ¤ì£¼ì„¸ìš”.

---

*ë³¸ ë¸”ë¡œê·¸ëŠ” MCI ì—°êµ¬ í•™ìŠµì„ ìœ„í•œ ëª©ì ìœ¼ë¡œ ìš´ì˜ë©ë‹ˆë‹¤.*
